Reagents News and Research

RSS

New Study Compares MALDI-TOF MS Assays for Detecting Carbapenemase Activity

Austrian researchers evaluate MALDI-TOF MS assays for carbapenemase detection, assessing their reliability and practicality in managing resistant infections.

18 Nov 2024

New Study Uncovers How Viral Infections Trigger Pain, Identifies Potential Target for Relief

Findings indicate nociceptors detect viral nucleic acids, activating STING and TRPV1, highlighting new pain mechanisms in viral infections like HSV-1.

23 Oct 2024

Automated DNA Separation for Sexual Assault Cases: A Breakthrough in On-Site Forensic Analysis

This study presents a digital microfluidics approach for rapid DNA extraction from sexual assault samples, significantly improving forensic analysis efficiency.

11 Sep 2024

New Map Reveals Hidden Interactions Between Receptors and Proteins

A single superfamily of receptors found on the surface of human cells is the target of one out of every three FDA-approved medications.

28 Aug 2024

Biotium Releases New High-Performance Magnetic Bead-Based FFPE DNA and RNA Extraction Kits Well-Suited for Automated Processes

Biotium, a leading supplier and inventor of fluorescent probes and other novel reagents for life science research, proudly announces the availability of high-throughput compatible magnetic-bead based versions of the CELLDATA DNAstorm™ and RNAstorm™ 2.0 FFPE Extraction Kits. Following the successful 2022 acquisition and integration of Cell Data Sciences' RNAstorm™ and DNAstorm™ kits, Biotium has enhanced these kits to streamline extraction of DNA or RNA from formalin-fixed, paraffin-embedded (FFPE) tissue samples.

From Biotium, Inc. 31 Jul 2024

Primerdesign Launches Real-Time PCR Workflow for Onsite Detection of Norovirus in Oysters

Primerdesign (part of the Novacyt Group), a company focussed on the design, manufacture, validation and supply of real-time PCR kits and reagents, today launched the genesig® Easy_oys Detection Kit for Norovirus in oysters.

From Primerdesign 26 Jun 2024

Ancestry Bias can Cause CRISPR Screens to Miss Cancer Dependencies

CRISPR/Cas9 gene editing has made possible a multitude of biomedical experiments including studies that systematically turn off genes in cancer cells to look for ones that the cancer cells heavily depend on to survive and grow.

17 Jun 2024

Simplified Proteomics Method Could Open the Door Toward Precision Medicine

Proteins are workhorses that carry out most of the biological functions in our cells.

12 Jun 2024

SPT Labtech Brings the Power of Miniaturization to More Genomics Researchers with mosquito® Gen3

SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, has expanded its nanoliter liquid handling portfolio with the launch of mosquito Gen3.

From SPT Labtech 12 Jun 2024

Viruses Offer Efficient Delivery for Precise Plant Breeding

The application of genome editing in plant molecular breeding is hampered by the lack of straightforward and efficient methods for introducing genome editing reagents into plants, despite the technology's great potential.

20 May 2024

Takara Bio Launches PrimeCap T7 RNA Polymerase for mRNA Therapy Development

Takara Bio announces the launch of PrimeCap™ T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development.

20 May 2024

Gyros Protein Technologies Launches Gyrolab Generic Rodent ADA Kit Reagents to Expedite Bioanalysis

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab Generic Rodent Anti-Drug Antibody (ADA) Kit Reagents for the detection of circulating immune complexes of human IgG with rodent anti-human IgG.

11 May 2024

Microfluidics Paves the Way for More Efficient Neural Stem Cell Generation

Swedish researchers have enhanced a method for transforming ordinary skin cells into neural stem cells, a development they believe narrows the accessibility gap for personalized cell-based therapies for Alzheimer's and Parkinson's diseases.

25 Apr 2024

SPT Labtech to Co-Market Streamlined NGS Library Preparation Workflows for Both PCR and PCR-Free Applications with Roche

SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, announces its co-marketing collaboration with Roche to deliver a streamlined method for Illumina-compatible Next Generation Sequencing (NGS) library preparation.

21 Mar 2024

Latest CRISPR-Cas Gene Editing Can Eliminate All Traces of HIV Virus From Infected Cells

New research presented early ahead of this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April) from a team of researchers in the Netherlands shows how the latest CRISPR-Cas gene editing technology can be used to eliminate all traces of the HIV virus from infected cells in the laboratory, raising hopes of a cure.

20 Mar 2024

The Impact of Catalysis for Site-Specific Protein Modification

As they recently reported in the journal Nature Chemistry, Boston College researchers have developed a new tool that can be used to develop novel biotherapeutics and protein-based research tools: the ability to precisely modify proteins using a mild charge of electricity.

6 Mar 2024

MIP Discovery Closes £7M Series a Financing to Drive Commercialization in Cell and Gene Therapy Space

MIP Discovery, an innovative developer of non-biological affinity reagents designed to accelerate the development and production of cell and gene therapies, today announced it has closed a £7 million GBP (~$9 million USD) Series A financing round, led by Mercia Ventures.

21 Feb 2024

Pore Power: High-Speed Droplet Production In Microfluidic Devices

Over the last two decades, ongoing research in microfluidics has faced challenges in applications due to the restricted productivity of microdroplets.

7 Feb 2024

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

From Bio-Techne 25 Jan 2024

Phage Proteins Tame CRISPR-Cas3, Paving Way for Precise Gene Therapy

Through the use of CRISPR, an immune system that bacteria use to defend themselves against viruses, researchers have been able to alter genetic information within cells.

22 Jan 2024